BeStock  
Stocks › Biotechnology › ANAB

AnaptysBio ANAB

US equityMarket cap rank #2932Biotechnology
$46.63 −$0.77 (-1.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.63 0.00%
Open$47.49
Prev close$47.40
Day range$46.05 – $47.71
Volume432.5K
Market cap$1.39B
P/E (TTM)9.0
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$80.00+71.6% vs. price
  • Buy 100%
Low $60.00Now $46.63Avg $80.00High $95.00

Recent rating changes

The last 20 actions on file set price targets from $60.00 to $95.00, averaging $83.39.

DateFirmRatingTarget
13 Nov 2026 Piper Sandler BUY $93.00
13 Nov 2026 H.C. Wainwright BUY $95.00
13 Nov 2026 Barclays BUY $75.00
26 Oct 2026 H.C. Wainwright BUY $95.00
21 Oct 2026 Leerink Partners BUY $81.00
19 Oct 2026 H.C. Wainwright BUY $95.00
5 Oct 2026 H.C. Wainwright BUY $95.00
30 Sep 2026 J.P. Morgan BUY $60.00
23 Sep 2026 Leerink Partners BUY $81.00
22 Sep 2026 UBS BUY $76.00
22 Sep 2026 H.C. Wainwright BUY $95.00
22 Sep 2026 Barclays BUY $75.00
18 Sep 2026 Leerink Partners BUY –
18 Sep 2026 Barclays BUY $75.00
25 Aug 2026 TD Cowen BUY –
24 Aug 2026 TD Cowen BUY $70.00
24 Aug 2026 H.C. Wainwright BUY $95.00
12 Aug 2026 H.C. Wainwright BUY $95.00
31 Jul 2026 Barclays BUY $75.00
23 Jul 2026 Barclays BUY $75.00

Discussion

No comments yet — be the first to weigh in on ANAB.

Sign in to join the discussion.

Scroll to Top